Aerie Pharma (AERI) Fireside Chat Implies Selloff is Overdone, PT to $40 at Stifel
Tweet Send to a Friend
Stifel analyst Annabel Samimy lowered the price target on Aerie Pharma (NASDAQ: AERI) to $40.00 (from $45.00) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE